Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Biomimetic Cornea fabrication by 3D printing and adult Mesenchymal Stem Cell directed differentiation.

Project description

Bioengineered cornea to replace donor grafts

Diseases impacting the cornea, the transparent part of the eye, often require transplantation. However, the shortage of donor tissue and the risk of immune rejection limit transplantation success. Regenerative medicine has emerged as a promising alternative, enabling the fabrication of tissues that closely replicate native human organs. With the support of the Marie Skłodowska-Curie Actions programme, the MIMECOR project aims to engineer an artificial cornea through 3D printing techniques and stem cell technology. This strategy aims to recapitulate the structure and function of the cornea, thereby addressing key limitations associated with current therapies. Ultimately, MIMECOR has the potential to improve patient outcomes and reduce dependence on corneal transplants.

Objective

MIMECOR aims to develop an artificial and biomimetic cornea to achieve a major improvement in the quality of life of corneal disease patients, reducing their dependence on corneal transplants. This will be reached through the preparation and further modifications of a human-like cornea through the combination of additive manufacturing, stem cell transdifferentiation, and colonisation as an alternative to natural cornea donation. This approach is going to be a major breakthrough in Ophthalmology, as it will overcome the existing limitations of current treatments: it could become a reference in the therapy for specific corneal pathologies. The candidate researcher, Dr. Marć will provide to the project with her broad experience in applied preclinical research, gained in academic and industrial research groups of different European countries. She will learn cutting-edge techniques in Regenerative Medicine applied to Ophthalmology, through the interaction with a multidisciplinary, collaborative, and creative environment with specialists in engineering, medicine, physics, biology, and biochemistry. The candidate will perfect research skills such as experimental design, scientific writing, open science and data analysis. Moreover, through diverse training activities and a non-academic placement at a small-medium enterprise (the largest monographic ophthalmological private hospital in Europe), Dr. Marć will also acquire transferable skills and experience in grant implementation, ethics in Responsible Research and Innovation, time management, and scientific communication and divulgation. Besides, this formative plan accommodates her needs with the capabilities of the hosting group and institution. All this knowledge and skills will be crucial for the career success of the researcher. Due to her knowledge of the local language, Dr. Marć intends to become an established biomedical scientist in Spain after MSCA-PF, applying for Spanish postdoctoral grants and positions.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ
Net EU contribution
€ 262 393,20
Address
PASEO DE LA CASTELLANA 261
28046 Madrid
Spain
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Other
Links
Total cost
No data

Partners (2)